TWI PHARMS FDA Approval ANDA 209603

ANDA 209603

TWI PHARMS

FDA Drug Application

Application #209603

Application Sponsors

ANDA 209603TWI PHARMS

Marketing Status

Prescription001
Prescription002
Prescription003

Application Products

001TABLET;ORAL100MG0LABETALOL HYDROCHLORIDELABETALOL HYDROCHLORIDE
002TABLET;ORAL200MG0LABETALOL HYDROCHLORIDELABETALOL HYDROCHLORIDE
003TABLET;ORAL300MG0LABETALOL HYDROCHLORIDELABETALOL HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2018-06-20STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB

CDER Filings

TWI PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 209603
            [companyName] => TWI PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"LABETALOL HYDROCHLORIDE","activeIngredients":"LABETALOL HYDROCHLORIDE","strength":"100MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"LABETALOL HYDROCHLORIDE","activeIngredients":"LABETALOL HYDROCHLORIDE","strength":"200MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"LABETALOL HYDROCHLORIDE","activeIngredients":"LABETALOL HYDROCHLORIDE","strength":"300MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"06\/20\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2018-06-20
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.